BAILLIE GIFFORD & CO – Adaptimmune Therapeutics plc Transaction History
BAILLIE GIFFORD & CO portfolio value:
$15.76M
portfolio value
BAILLIE GIFFORD & CO quarter portfolio value change:
-36.76%
quarter
Adaptimmune Therapeutics plc 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.28% | -656.41K shares | -10.28M | $1.08 | 14.66M |
| Q2 2022 | share | Decrease | -0.38% | -59.19K shares | -5.63M | $1.7 | 15.32M |
| Q1 2022 | share | Increase | +11.81% | 1.62M shares | -19.90M | $2.06 | 15.38M |
| Q4 2021 | share | Increase | +7.26% | 931.37K shares | -14.71M | $3.87 | 13.75M |
| Q3 2021 | share | Increase | +9.64% | 1.12M shares | 16.47M | $5.17 | 12.82M |
| Q2 2021 | share | Increase | +2.00% | 229.40K shares | -11.06M | $4.26 | 11.69M |
| Q1 2021 | share | Increase | +10.71% | 1.10M shares | 5.06M | $5.31 | 11.46M |
| Q4 2020 | share | Increase | +46.34% | 3.27M shares | -654K | $5.39 | 10.35M |
| Q3 2020 | share | Increase | +33.81% | 1.78M shares | 3.53M | $7.98 | 7.07M |
| Q2 2020 | share | Increase | +21.49% | 935.64K shares | 41.10M | $10.01 | 5.28M |
| Q1 2020 | share | Increase | +1.55% | 66.47K shares | 6.69M | $2.72 | 4.35M |
| Q4 2019 | share | Increase | +2.95% | 122.73K shares | -1.14M | $1.2 | 4.28M |
| Q3 2019 | share | Increase | +0.51% | 20.96K shares | -10.36M | $1.51 | 4.16M |
| Q2 2019 | share | Increase | +7.94% | 304.65K shares | 150K | $4.02 | 4.14M |
| Q1 2019 | share | Increase | +3.78% | 139.66K shares | -4.76M | $4.3 | 3.83M |
| Q4 2018 | share | Increase | +8.25% | 281.89K shares | -25.07M | $5.75 | 3.69M |
| Q3 2018 | share | Increase | +12.67% | 384.36K shares | 10.33M | $13.56 | 3.41M |
| Q2 2018 | share | Increase | +18.24% | 467.85K shares | 7.19M | $11.87 | 3.03M |
| Q1 2018 | share | Increase | +33.57% | 644.81K shares | 15.98M | $11.23 | 2.56M |
| Q4 2017 | share | Increase | +39.24% | 541.28K shares | 1.53M | $6.68 | 1.92M |
| Q3 2017 | share | Increase | +4.23% | 55.99K shares | 5.35M | $8.19 | 1.37M |
| Q2 2017 | share | Increase | +43.68% | 402.32K shares | 866K | $4.49 | 1.32M |
| Q1 2017 | share | 0.00% | 0 shares | 1.34M | $5.51 | 920.98K | |
| Q4 2016 | share | 0.00% | 0 shares | -2.76M | $4.05 | 920.98K | |
| Q3 2016 | share | Increase | +114.33% | 491.28K shares | 2.99M | $7.05 | 920.98K |
| Q2 2016 | share | 0.00% | 0 shares | 9K | $8.15 | 429.7K | |
| Q1 2016 | share | Increase | 0.00% | 429.7K shares | 3.49M | $8.13 | 429.7K |